DiaSorin SpA Announces 8% Share‑Buyback to Boost Confidence Amid European Market Sell‑Off
DiaSorin SpA launches an 8 % share‑buyback amid a sharp European sell‑off, signaling confidence in its undervalued diagnostics business and potential upside for shareholders.
3 minutes to read